Literature DB >> 20112403

Excessive interleukin-1 signaling determines the development of Th1 and Th17 responses in chronic inflammation.

Leo A B Joosten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20112403     DOI： 10.1002/art.27242

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  8 in total

1.  Epidermal Fatty Acid binding protein promotes skin inflammation induced by high-fat diet.

Authors:  Yuwen Zhang; Qiang Li; Enyu Rao; Yanwen Sun; Michael E Grossmann; Rebecca J Morris; Margot P Cleary; Bing Li
Journal:  Immunity       Date:  2015-05-19       Impact factor: 31.745

2.  Th17 Responses to Collagen Type V, kα1-Tubulin, and Vimentin Are Present Early in Human Development and Persist Throughout Life.

Authors:  J A Sullivan; E Jankowska-Gan; S Hegde; M A Pestrak; V V Agashe; A C Park; M E Brown; J F Kernien; D S Wilkes; D B Kaufman; D S Greenspan; W J Burlingham
Journal:  Am J Transplant       Date:  2016-12-19       Impact factor: 8.086

Review 3.  Interleukin-1 in the pathogenesis and treatment of inflammatory diseases.

Authors:  Charles A Dinarello
Journal:  Blood       Date:  2011-02-08       Impact factor: 22.113

Review 4.  The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs).

Authors:  Gerwyn Morris; Michael Berk; Piotr Galecki; Michael Maes
Journal:  Mol Neurobiol       Date:  2013-09-26       Impact factor: 5.590

Review 5.  Interleukin-18 and IL-18 binding protein.

Authors:  Charles A Dinarello; Daniela Novick; Soohyun Kim; Gilles Kaplanski
Journal:  Front Immunol       Date:  2013-10-08       Impact factor: 7.561

Review 6.  Major involvement of bacterial components in rheumatoid arthritis and its accompanying oxidative stress, systemic inflammation and hypercoagulability.

Authors:  Etheresia Pretorius; Oore-Ofe Akeredolu; Prashilla Soma; Douglas B Kell
Journal:  Exp Biol Med (Maywood)       Date:  2016-11-26

7.  IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection.

Authors:  Claudia Gonzalez-Lombana; Ciara Gimblet; Olivia Bacellar; Walker W Oliveira; Sara Passos; Lucas P Carvalho; Michael Goldschmidt; Edgar M Carvalho; Phillip Scott
Journal:  PLoS Pathog       Date:  2013-03-21       Impact factor: 6.823

8.  An oral alpha-galactosylceramide adjuvanted Helicobacter pylori vaccine induces protective IL-1R- and IL-17R-dependent Th1 responses.

Authors:  Stephanie Longet; Aine Abautret-Daly; Sukanya Raghavan; Ed C Lavelle; Christopher J H Davitt; Craig P McEntee; Vincenzo Aversa; Monica Rosa; Ivan S Coulter; Jan Holmgren
Journal:  NPJ Vaccines       Date:  2019-10-25       Impact factor: 7.344
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.